Current and former members of the FDA told CNN about issues with the Elsa generative AI tool unveiled by the federal agency last month. Three employees said that in practice, Elsa has hallucinated nonexistent studies or misrepresented real research. "Anything that you don't have time to double-check is unreliable," one source told the publication. "It hallucinates confidently." Which isn't exactly ideal for a tool that's supposed to be speeding up the clinical review process and aiding with making efficient, informed decisions to benefit patients.<br /> Leadership at the FDA appeared unfazed by the potential problems posed by Elsa. "I have not heard those specific concerns," FDA Commissioner Marty Makary told CNN. He also emphasized that u [...]
The FDA has launched the generative AI tool, Elsa, agency-wide to help its employees with everything from clinical reviews to investigations. Sure, we're living in a time of widespread disinforma [...]
US District Judge John D. Bates has ordered (PDF) the Center for Disease Control and Food and Drug Administration to restore the web pages and resources they had previously removed to comply with Pres [...]
Nvidia CEO Jensen Huang claims in a CNBC interview that AI no longer hallucinates. At best, that's a massive oversimplification. At worst, it's misleading. Either way, nobody pushes back, wh [...]
Nuance Audio, new "hearing glasses" from EssilorLuxottica, have received FDA clearance and "a CE marking under the Medical Devices regulation in the EU," making them officially rea [...]
Newly restored pages on the websites of government agencies like the Food and Drug Administration (FDA) and Substance Abuse and Mental Health Services Administration (SAMHSA) now include a disclaimer [...]
The US Food and Drug Administration is relying on Elsa, a generative AI system, to help evaluate new drugs - even though, according to insiders, it regularly fabricates studies.<br /> The articl [...]
Amazon just introduced an AI tool that will automatically translate books into other languages. The appropriately-named Kindle Translate is being advertised as a resource for authors that self publish [...]